Structural and cognitive deficits in remitting and non-remitting recurrent depression: a voxel-based morphometric...

Area of Science:

• Neuroscience
• Psychiatry
• Neuroimaging

Background:

• Major depressive disorder (MDD) remission is optimal, but many patients show poor response to antidepressants.
• Treatment resistance in MDD can lead to cognitive decline and structural brain abnormalities.
• Previous research suggests a link between brain structure and clinical response in MDD.

Purpose of the Study:

• To investigate gray matter volume (GMV) differences between remitting and non-remitting MDD patients.
• To correlate structural abnormalities with cognitive functioning in MDD.
• To identify potential neurobiological markers for antidepressant treatment response.

Main Methods:

• Voxel-based morphometry (VBM) and neuropsychological testing were used.
• Compared 44 adults with recurrent MDD (19 remitting, 25 non-remitting) to 25 healthy controls.
• Assessed patients after a 6-week antidepressant trial, defining remission by specific rating scale scores.

Main Results:

• Remitting MDD patients showed milder visual attention deficits, linked to reduced GMV in the left postcentral gyrus (BA 3) and bilateral medial/superior frontal gyrus (BA 6).
• Non-remitting MDD patients exhibited reduced GMV in the left dorsolateral prefrontal cortex (DLPFC, BA 9).
• Non-remitters displayed impaired acoustic and visual attention associated with GMV differences in cortical regions, thalamus, and amygdala/parahippocampal gyrus.

Conclusions:

• Patients achieving MDD remission are cognitively and morphologically distinct from non-remitters.
• Structural deficits in the left DLPFC may characterize MDD subgroups with poor antidepressant response.
• VBM analysis reveals specific brain regions associated with treatment outcomes in MDD.